LENSOLQA Trademark

Trademark Overview


On Friday, September 16, 2022, a trademark application was filed for LENSOLQA with the United States Patent and Trademark Office. The USPTO has given the LENSOLQA trademark a serial number of 97595395. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 20, 2024. This trademark is owned by Gilead Sciences Ireland UC. The LENSOLQA trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
lensolqa

General Information


Serial Number97595395
Word MarkLENSOLQA
Filing DateFriday, September 16, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 10, 2024ASSIGNED TO LIE
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Wednesday, August 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2023ASSIGNED TO EXAMINER
Tuesday, September 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022NEW APPLICATION ENTERED